Get started
Author

Syed K. Hasan

Observed names: Hasan, Syed K., Hasan, Syed Khizer, S. K. Hasan, S.K. Hasan, Syed Hasan, Syed Hasan K, Syed Hasan Khizer, Syed K Hasan, Syed Khaizer Hasan, Syed Khizar Hasan, Syed Khizer Hasan
Observed institutions: University of Rome Tor Vergata, Bhabha Atomic Research Centre, Homi Bhabha National Institute, Tata Memorial Hospital, Azienda Ospedaliero-Universitaria Careggi, Fondazione Santa Lucia, Advanced Centre for Treatment, Research and Education in Cancer, University of Florence, All India Institute of Medical Sciences
ORCID: 0000-0001-9580-5183
Observed ORCID: 0000-0001-9580-5183
OpenAlex ID: A5087775526
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
2021 · Nikhil Patkar, Chinmayee Kakirde, et al. · Leukemia · 104
PDF
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
2008 · Syed Khizer Hasan, Ashley N. Mays, et al. · Blood · 82
PDF
Understanding the molecular pathogenesis of acute promyelocytic leukemia
2014 · Francesco Lo-Coco, Syed Khizer Hasan · Best Practice & Research Clinical Haematology · 81
Acute myeloid leukemia developing in patients with autoimmune diseases
2011 · S. M. Ramadan, T. M. Fouad, et al. · Haematologica · 73
PDF
Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia
2009 · Ashley N. Mays, Neil Osheroff, et al. · Blood · 68
Identification of emerging FLT 3 ITD ‐positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin
2013 · Tiziana Ottone, Serena Zaza, et al. · British Journal of Haematology · 41
Risk of acute promyelocytic leukemia in multiple sclerosis
2011 · S.K. Hasan, F. Buttari, et al. · Neurology · 35
Molecular Pathogenesis of Secondary Acute Promyelocytic Leukemia
2011 · Melanie Joannides, Ashley N Mays, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 34
PDF
Analysis of t(15;17) chromosomal breakpoint sequences in therapy‐related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci
2010 · Syed Khizer Hasan, Tiziana Ottone, et al. · Genes Chromosomes and Cancer · 34
Improved protocol for plasma microRNA extraction and comparison of commercial kits
2021 · Harshini Sriram, Nilesh Deshpande, et al. · Biochemia Medica · 30
PDF
Inhibition of novel GCN5–ATM axis restricts the onset of acquired drug resistance in leukemia
2018 · Sameer Salunkhe, Saket V. Mishra, et al. · International Journal of Cancer · 26
PDF
Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers
2025 · Syed K. Hasan, Sundarraj Jayakumar, et al. · Cells · 25
PDF
Identification of a potential “hotspot” DNA region in the RUNX1 gene targeted by mitoxantrone in therapy‐related acute myeloid leukemia with t(16;21) translocation
2008 · Tiziana Ottone, Syed Khizer Hasan, et al. · Genes Chromosomes and Cancer · 23
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
2023 · Tarang Gaur, Ramulu Poddutoori, et al. · Journal of Experimental & Clinical Cancer Research · 22
PDF
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
2019 · Nikhil Patkar, Anam Fatima Shaikh, et al. · Blood Cancer Journal · 22
PDF
Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis
2010 · E. Ammatuna, P. Montesinos, et al. · Haematologica · 21
PDF
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
2019 · Nikhil Patkar, Chinmayee Kakirde, et al. · Frontiers in Oncology · 20
PDF
Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia
2019 · V. Alfonso, L. Iaccarino, et al. · Leukemia · 20
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
2024 · Prashant R. Tembhare, Harshini Sriram, et al. · HemaSphere · 18
PDF
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations
2014 · Margherita Bodini, Chiara Ronchini, et al. · Blood · 18
PDF
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit
2018 · Navin Khattry, Siddhartha Laskar, et al. · Indian Journal of Cancer · 17
Biology and management of therapy-related acute promyelocytic leukemia
2013 · Francesco Lo-Coco, Syed K. Hasan, et al. · Current Opinion in Oncology · 17
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39
2019 · Ekaterina S. Kuligina, Anna P. Sokolenko, et al. · Breast Cancer Research and Treatment · 16
Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: Prognostic implications
2007 · Syed K Hasan, Sudha Sazawal, et al. · Hematology · 15
PDF
Haematological & molecular profile of acute myelogenous leukaemia in India.
2009 · Sudha Sazawal, Bijender Kumar, et al. · PubMed · 14
Works count: 101
Citation count: 1,076
H-index: 18
I10-index: 32
Year
Topic
Type